Home › Funds › Boxer Capital Management, LLC › CORT
Boxer Capital Management, LLC position in CORT
CORCEPT THERAPEUTICS INC · Health Care
Boxer Capital Management, LLC reported holding 335,500 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$29.2M, representing 2.20% of its reported portfolio and ranking #13 among its reported holdings. Boxer Capital Management, LLC has disclosed CORT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's CORT position evolved
Boxer Capital Management, LLC first disclosed a stake in CORT in Q1 2026 at 250,000 shares (US$10.1M). The position peaked in Q2 2026 at 335,500 shares, worth US$29.2M. Across 2 filings, Boxer Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 335,500 shares valued at US$29.2M — an increase of 85,500 shares quarter over quarter.. Notable position changes include a 34% increase in Q2 2026 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 250.00K | $10.08M | New |
| Q2 2026 | 335.50K | $29.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$457.5M), Parallel Advisors, LLC (US$344.5M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 5.26M sh · $457.50M · Q2 2026
- Parallel Advisors, LLC 3.96M sh · $344.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- EMERALD ADVISERS, LLC 748.33K sh · $65.07M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 464.90K sh · $40.42M · Q2 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held CORT?
Boxer Capital Management, LLC has disclosed CORT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Boxer Capital Management, LLC's current position in CORT?
As of Q2 2026, Boxer Capital Management, LLC holds 335.50K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $29.17M, representing 2.20% of its reported portfolio and ranking #13.
Has Boxer Capital Management, LLC been buying or selling CORT?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC increased its position in CORT. The position peaked in Q2 2026 at 335.50K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.